Data from the phase III INTERACT3 study demonstrate that a new combination of treatments for stroke due to intracerebral hemorrhage (ICH) significantly improves the chances of surviving without major disability. The INTERACT3 study is the first-ever randomized controlled trial to show a clearly positive outcome for the treatment of ICH. Timely administration of the new treatment protocol—known as a Care Bundle—centered on the rapid control of high blood pressure, led to improved recovery, lower rates of death, and better overall quality of life. Professor Craig Anderson said, "Despite the high rates of ICH and its severity, there are few proven...